We are live on ! Find out more
VIGL

Vigil Neuroscience
VIGL

Delisted

VIGL was delisted on the 4th of August, 2025.

Back to rankings

37 hedge funds and large institutions have $312M invested in Vigil Neuroscience in 2022 Q4 according to their latest regulatory filings, with 9 funds opening new positions, 12 increasing their positions, 7 reducing their positions, and 5 closing their positions.

New
Increased
Maintained
Reduced
Closed

80% more first-time investments, than exits

New positions opened: 9 | Existing positions closed: 5

71% more repeat investments, than reductions

Existing positions increased: 12 | Existing positions reduced: 7

43% more capital invested

Capital invested by funds: $219M → $312M (+$93.4M)

33% more funds holding in top 10

Funds holding in top 10: 3 → 4 (+1)

12% more funds holding

Funds holding: 33 → 37 (+4)

16.64% less ownership

Funds ownership: 86.86% → 70.22% (-17%)

Holders
37
Holders Change
+4
Holders Change %
+12.12%
% of All Funds
0.59%
Holding in Top 10
4
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+33.33%
% of All Funds
0.06%
New
9
Increased
12
Reduced
7
Closed
5
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
Vanguard Group
Vanguard Group
Pennsylvania
+$4.56M
2
Fidelity Investments
Fidelity Investments
Massachusetts
+$733K
3
Bank of Montreal
Bank of Montreal
Ontario, Canada
+$713K
4
O
OrbiMed
New York
+$463K
5
Geode Capital Management
Geode Capital Management
Massachusetts
+$392K

Top Sellers

Rank Fund Capital Flow
1
DTC
Deep Track Capital
Connecticut
-$3.18M
2
DCM
DAFNA Capital Management
California
-$584K
3
AG
Artal Group
Luxembourg
-$518K
4
E
Ergoteles
New York
-$260K
5
LGM
Logos Global Management
California
-$211K
Name Holding Trade Value Shares
Change 		Change in
Stake
AVLSA
1
Atlas Venture Life Science Advisors
Massachusetts
$73M – – –
NV
2
Northpond Ventures
Maryland
$52.7M – – –
AG
3
Artal Group
Luxembourg
$28M -$518K -42,222 -2%
Citadel Advisors
4
Citadel Advisors
Florida
$27M -$31.3K -2,551 -0.1%
DTC
5
Deep Track Capital
Connecticut
$26.3M -$3.18M -259,014 -11%
DM
6
Deerfield Management
New York
$25.7M -$34.2K -2,784 -0.1%
BI
7
BVF Inc
California
$22.7M – – –
Vanguard Group
8
Vanguard Group
Pennsylvania
$9.21M +$4.56M +371,587 +102%
CAM
9
Cormorant Asset Management
Massachusetts
$7.71M – – –
PBPIA
10
Pivotal bioVenture Partners Investment Advisor
California
$7.01M – – –
RSCM
11
Rock Springs Capital Management
Maryland
$5.9M – – –
O
12
OrbiMed
New York
$5.61M +$463K +37,700 +9%
HMC
13
Harvard Management Company
Massachusetts
$3.62M – – –
TOCUITCONY
14
Trustees of Columbia University in the City of New York
New York
$2.41M +$2.37M +192,973 New
LGM
15
Logos Global Management
California
$2.35M -$211K -17,205 -8%
DCM
16
DAFNA Capital Management
California
$2.11M -$584K -47,549 -22%
LCM
17
Laurion Capital Management
New York
$1.63M – – –
Barclays
18
Barclays
United Kingdom
$1.32M +$45.8K +3,730 +4%
Geode Capital Management
19
Geode Capital Management
Massachusetts
$1.3M +$392K +31,948 +44%
BlackRock
20
BlackRock
New York
$1.28M +$8.18K +666 +0.7%
Citigroup
21
Citigroup
New York
$1.17M +$322K +26,272 +39%
Fidelity Investments
22
Fidelity Investments
Massachusetts
$1.08M +$733K +59,695 +221%
Goldman Sachs
23
Goldman Sachs
New York
$913K -$160 -13 -0%
Bank of Montreal
24
Bank of Montreal
Ontario, Canada
$726K +$713K +58,100 New
State Street
25
State Street
Massachusetts
$447K +$176K +14,365 +67%
1
2

VIGL Hedge Fund Activity: Q4 2022 in Review

37 of the 6,222 institutional investors tracked by Wall St. Rank reported a position in Vigil Neuroscience (VIGL) for Q4 2022, worth a combined $312M — up 43% from $219M a quarter earlier.

Buyers outnumbered sellers: 9 funds opened new VIGL positions and 5 closed out — a net gain of 4 holders — while 12 added to existing stakes and 7 trimmed.

The largest buyer was Vanguard Group, adding an estimated $4.56M. The largest seller was Deep Track Capital, cutting an estimated $3.18M.

  • 37 institutional investors held Vigil Neuroscience (VIGL) as of Q4 2022, up from 33 in Q3 2022.
  • Funds reported $312M of Vigil Neuroscience stock for Q4 2022, up 43% quarter-over-quarter.
  • 9 funds opened new Vigil Neuroscience positions in Q4 2022 and 5 closed out, a net change of +4 holders.
  • The largest Vigil Neuroscience buyer in Q4 2022 was Vanguard Group, an estimated $4.56M added.
  • The largest Vigil Neuroscience seller in Q4 2022 was Deep Track Capital, an estimated $3.18M sold.

Based on aggregated 13F filings for Q4 2022.